{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:18:55Z","timestamp":1768587535216,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["PX2019014"],"award-info":[{"award-number":["PX2019014"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.msard.2018.10.114","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T21:51:42Z","timestamp":1540849902000},"page":"254-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Disruption of blood-brain barrier integrity associated with brain lesions in Chinese neuromyelitis optica spectrum disorder patients"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8304-6685","authenticated-orcid":false,"given":"Xiaofan","family":"You","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lirong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2018.10.114_bib0001","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jns.2018.02.020","article-title":"Oligoclonal bands and periventricular lesions in multiple sclerosis will not increase blood-brain barrier permeability","volume":"387","author":"Akaishi","year":"2018","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.msard.2018.10.114_bib0002","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00415-005-0817-9","article-title":"Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases","volume":"252","author":"Brettschneider","year":"2005","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2018.10.114_bib0003","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.56.4.507","article-title":"MS and neuromyelitis optica in Martinique (French West Indies)","volume":"56","author":"Cabre","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2018.10.114_bib0004","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1352458506070725","article-title":"Brain magnetic resonance imaging findings in relapsing neuromyelitis optica","volume":"13","author":"Cabrera-Gomez","year":"2007","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.msard.2018.10.114_bib0005","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneurol.2011.249","article-title":"Brain involvement in neuromyelitis optica spectrum disorders","volume":"68","author":"Chan","year":"2011","journal-title":"Arch. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2018.10.114_bib0006","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3181d31e35","article-title":"Neuromyelitis optica in France: a multicenter study of 125 patients","volume":"74","author":"Collongues","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2018.10.114_bib0007","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaneurol.2016.5441","article-title":"Association of extension of cervical cord lesion and area postrema syndrome with neuromyelitis optica spectrum disorder","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.msard.2018.10.114_bib0008","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2018.10.114_bib0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","article-title":"Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica","volume":"251","author":"Ghezzi","year":"2004","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2018.10.114_bib0010","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuroscience.2009.08.032","article-title":"Neurological autoimmunity targeting aquaporin-4","volume":"168","author":"Hinson","year":"2010","journal-title":"Neuroscience"},{"issue":"1-2","key":"10.1016\/j.msard.2018.10.114_bib0011","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2011.04.009","article-title":"Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood-brain barrier","volume":"236","author":"Hosokawa","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.msard.2018.10.114_bib0012","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.21753","article-title":"\"Cloud-like Enhancement\" is a magnetic resonance imaging abnormality specific to neuromyelitis optica","volume":"66","author":"Ito","year":"2009","journal-title":"Ann. Neurol."},{"issue":"1-2","key":"10.1016\/j.msard.2018.10.114_bib0013","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","article-title":"Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen","volume":"291","author":"Jarius","year":"2010","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.msard.2018.10.114_bib0014","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jnnp-2016-314005","article-title":"Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease","volume":"88","author":"Jury\u0144czyk","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.msard.2018.10.114_bib0015","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.msard.2018.10.114_bib0016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2010.12.001","article-title":"Brain abnormalities in neuromyelitis optica","volume":"302","author":"Kim","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.msard.2018.10.114_bib0017","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1007\/s00415-011-6086-x","article-title":"Cerebrospinal fluid\/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica","volume":"258","author":"Kim","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2018.10.114_bib0018","article-title":"Brain abnormalities in neuromyelitis optica spectrum disorder","volume":"2012","author":"Kim","year":"2012","journal-title":"Mult. Scler. Int."},{"issue":"9","key":"10.1016\/j.msard.2018.10.114_bib0019","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/1352458511404917","article-title":"Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder","volume":"17","author":"Kim","year":"2011","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.msard.2018.10.114_bib0020","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1177\/1352458513507822","article-title":"Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients","volume":"20","author":"Kremer","year":"2014","journal-title":"Mult. Scler. J."},{"issue":"11","key":"10.1016\/j.msard.2018.10.114_bib0021","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2018.10.114_bib0022","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0404.2008.01012.x","article-title":"Brain magnetic resonance imaging abnormalities in neuromyelitis optica","volume":"118","author":"Li","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2018.10.114_bib0023","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12883-014-0218-8","article-title":"Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients","volume":"14","author":"Liao","year":"2014","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.msard.2018.10.114_bib0024","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol."},{"issue":"9","key":"10.1016\/j.msard.2018.10.114_bib0025","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/brain\/awq177","article-title":"Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury","volume":"133","author":"Marignier","year":"2010","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.msard.2018.10.114_bib0026","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/01.wnl.0000183151.19351.82","article-title":"Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica","volume":"65","author":"Misu","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.msard.2018.10.114_bib0027","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jocn.2011.10.009","article-title":"Brain MRI abnormalities in Brazilian patients with neuromyelitis optica","volume":"19","author":"Pires","year":"2012","journal-title":"J. Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.msard.2018.10.114_bib0028","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2018.10.114_bib0029","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.12794","article-title":"Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later","volume":"1366","author":"Pittock","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.msard.2018.10.114_bib0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF)\u2013a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases","volume":"122","author":"Reiber","year":"1994","journal-title":"J. Neurol. Sci."},{"issue":"1-2","key":"10.1016\/j.msard.2018.10.114_bib0031","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jns.2009.05.022","article-title":"Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica","volume":"284","author":"Saiki","year":"2009","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2018.10.114_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122000","article-title":"Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica","volume":"10","author":"Shimizu","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.msard.2018.10.114_bib0033","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jnnp-2011-300434","article-title":"Sera from neuromyelitis optica patients disrupt the blood\u2013brain barrier","volume":"83","author":"Shimizu","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.msard.2018.10.114_bib0034","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp-2013-305907","article-title":"Autocrine MMP-2\/9 secretion increases the BBB permeability in neuromyelitis optica","volume":"85","author":"Tasaki","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.msard.2018.10.114_bib0035","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1177\/147323001204000427","article-title":"Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability","volume":"40","author":"Tomizawa","year":"2012","journal-title":"J. Int. Med. Res."},{"issue":"8","key":"10.1016\/j.msard.2018.10.114_bib0036","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1177\/1352458516672015","article-title":"Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: their possible role on blood-brain barrier disruption","volume":"23","author":"Uchida","year":"2017","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2018.10.114_bib0037","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/1352458515601903","article-title":"Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later","volume":"22","author":"Uher","year":"2016","journal-title":"Mult. Scler. J."},{"issue":"7","key":"10.1016\/j.msard.2018.10.114_bib0038","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneurol.2011.148","article-title":"Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica","volume":"68","author":"Uzawa","year":"2011","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2018.10.114_bib0039","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2018.10.114_bib0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejrad.2010.06.024","article-title":"Brain MRI abnormalities in neuromyelitis optica","volume":"80","author":"Wang","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.msard.2018.10.114_bib0041","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fneur.2018.00648","article-title":"Blood brain barrier permeability could be a biomarker to predict severity of neuromyelitis optica spectrum disorders: a retrospective analysis","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2018.10.114_bib0042","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2018.10.114_bib0043","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818304814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818304814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:46:22Z","timestamp":1761900382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034818304814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":43,"alternative-id":["S2211034818304814"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.10.114","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruption of blood-brain barrier integrity associated with brain lesions in Chinese neuromyelitis optica spectrum disorder patients","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.10.114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}